Chengdu, China

Guoliang Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sichuan Haisco Pharmaceutical Co., Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guoliang Liu. Retrieved from https://idiyas.com/inventor/guoliang-liu-gap93x5a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guoliang Liu: Innovator in Pharmaceutical Chemistry

Introduction

Guoliang Liu is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on phenol derivatives.

Latest Patents

Liu holds a patent for a phenol derivative and its preparation method, which has applications in medicine. The invention relates to a phenol derivative represented by a specific general formula, along with its stereoisomers, solvates, metabolites, prodrugs, pharmaceutically acceptable salts, or cocrystals. This compound is particularly relevant in the field of the central nervous system.

Career Highlights

Guoliang Liu is associated with Sichuan Haisco Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new pharmaceutical compositions that can benefit various medical applications.

Collaborations

Liu collaborates with talented colleagues, including Linlin Qin and Fangqiong Li, who contribute to his research endeavors.

Conclusion

Guoliang Liu's innovative work in the development of phenol derivatives showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…